Razia Moorad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Razia Moorad has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Dirk Peter Dittmer
Lineberger Comprehensive Cancer Center and Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill
4 shared publications - Angelica Juarez
UNC Lineberger Comprehensive Cancer Center and Center for AIDS Research, Chapel Hill, North Carolina, USA
3 shared publications - Linda J. Pluta
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina
2 shared publications Ahmed Al Qaffas
Department of Pediatrics, Medical College of Virginia campus of Virginia Commonwealth University, 1101 E. Marshall Street, Richmond, VA, 23298-0163, USA
1 shared publication- Alice Peng
UNC Lineberger Comprehensive Cancer Center and Center for AIDS Research, Chapel Hill, North Carolina, USA
1 shared publication - Allison Silverstein
Section of Palliative Medicine, Department of Paediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA
1 shared publication
Latest Publications
- Open Access
- 22 November 2023
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (22)
Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease
BACKGROUND: Kaposi sarcoma (KS) is among the most common childhood cancers in Eastern and Central Africa. Pediatric KS has a distinctive clinical presentation compared with adult KS, which includes a tendency for primary lymph node involvement, a considerable proportion of patients lacking cutaneous lesions, and a potential for fulminant disease. The molecular mechanisms or correlates for these disease features are unknown. METHODS: This was a cross-sectional study. All cases were confirmed by IHC for KS-associated herpesvirus (KSHV) LANA protein. Baseline blood samples were profiled for HIV and KSHV genome copy numbers by qPCR and secreted cytokines by ELISA. Biopsies were characterized for viral and human transcription, and KSHV genomes were determined when possible. RESULTS: Seventy participants with pediatric KS were enrolled between June 2013 and August 2019 in Malawi and compared with adult patients with KS. They exhibited high KSHV genome copy numbers and IL-6/IL-10 levels. Four biopsies (16%) had a viral transcription pattern consistent with lytic viral replication. CONCLUSION: The unique features of pediatric KS may contribute to the specific clinical manifestations and may direct future treatment options. FUNDING: US National Institutes of Health U54-CA-254569, PO1-CA019014, U54-CA254564, RO1-CA23958.
- 22 November 2023
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (22)
Open AccessPediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease
BACKGROUND: Kaposi sarcoma (KS) is among the most common childhood cancers in Eastern and Central Africa. Pediatric KS has a distinctive clinical presentation compared with adult KS, which includes a tendency for primary lymph node involvement, a considerable proportion of patients lacking cutaneous lesions, and a potential for fulminant disease. The molecular mechanisms or correlates for these disease features are unknown. METHODS: This was a cross-sectional study. All cases were confirmed by IHC for KS-associated herpesvirus (KSHV) LANA protein. Baseline blood samples were profiled for HIV and KSHV genome copy numbers by qPCR and secreted cytokines by ELISA. Biopsies were characterized for viral and human transcription, and KSHV genomes were determined when possible. RESULTS: Seventy participants with pediatric KS were enrolled between June 2013 and August 2019 in Malawi and compared with adult patients with KS. They exhibited high KSHV genome copy numbers and IL-6/IL-10 levels. Four biopsies (16%) had a viral transcription pattern consistent with lytic viral replication. CONCLUSION: The unique features of pediatric KS may contribute to the specific clinical manifestations and may direct future treatment options. FUNDING: US National Institutes of Health U54-CA-254569, PO1-CA019014, U54-CA254564, RO1-CA23958.
- Open Access
- 1 November 2020
- Published by Elsevier in Cell Reports
- Vol. 33 (5) , 108352
High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States
- 1 November 2020
- Published by Elsevier in Cell Reports
- Vol. 33 (5) , 108352
Open AccessHigh-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States